Recent publication:
Multicentre evaluation of a EUCAST-based agar-screening method for terbinafine and itraconazole susceptibility of Trichophyton spp.
Meletiadis J, Siopi M, Jørgensen KM, Escribano P, van de Lee H, Buil JB, Friberg N, Guinea J, Arendrup MC. Clin Microbiol Infect. 2025 Jul 22:S1198-743X(25)00352-0. doi: 10.1016/j.cmi.2025.07.012
Review 2024
Twenty Years in EUCAST Anti‑Fungal Susceptibility Testing: Progress & Remaining Challenges
Maiken Cavling Arendrup, Jesús Guinea, Joseph Meletiadis. Mycopathologia. 2024 Jul 11;189(4):64. doi:10.1007/s11046-024-00861-2. PMID:38990395
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established EUCAST breakpoints
Maiken Cavling Arendrup, Jesus Guinea, Sevtap Arikan‑Akdagli, Eelco F. J. Meijer, Jacques F. Meis, Jochem B. Buil, Eric Dannaoui, Christian G. Giske, Pavlina Lyskova, Joseph Meletiadis, et al.; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clinical Microbiology and Infection. Published online July 10, 2025. doi:10.1016/j.cmi.2025.07.002.
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.
Thomas R. Rogers, Paul E. Verweij, Mariana Castanheira, Eric Dannaoui, P. Lewis White, Maiken Cavling Arendrup; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Journal of Antimicrobial Chemotherapy. 2022;77(8):2053–2073. doi:10.1093/jac/dkac161.
Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidiaforming dermatophytes.
Maiken Cavling Arendrup, Karin Meinike Jørgensen, Jesus Guinea, Katrien Lagrou, Erja Chryssanthou, Marie-Pierre Hayette, Francesco Barchiesi, Cornelia Lass-Flörl, Petr Hamal Eric Dannaoui, Anuradha Chowdhary, Rasmus Krøger Hare and Joseph Meletiadis. Journal of Antimicrobial Chemotherapy, Volume 77, Issue 4, April 2022, Pages 1209–1210, https://doi.org/10.1093/jac/dkac004
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee onantimicrobial susceptibility testing (EUCAST).
Maiken Cavling Arendrup, Jesus Guinea, Sevtap Arikan-Akdagli, Eelco F. J. Meijer, Jacques F. Meis, Jochem B. Buil, Eric Dannaoui, Christian G. Giske, Pavlina Lyskova, Joseph Meletiadis, et al.; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clinical Microbiology and Infection. Published online June 16, 2020. doi:10.1016/j.cmi.2020.06.007.
Development and multicentre validation of an agar-based screening method for echinocandin susceptibilty testing of Aspergillus species.
Joseph Meletiadis, Maria Siopi, Lamprini Kanioura, Karin Meinike Jørgensen, David S Perlin, Johan W Mouton, Maiken Cavling Arendrup. Journal of Antimicrobial Chemotherapy, Volume 74, Issue 8, August 2019, Pages 2247–2254 https://doi.org/10.1093/jac/dkz154
How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates. 
Jesus Guinea, Paul E. Verweij, Joseph Meletiadis, Jan-Willem Mouton, Francesco Barchiesi, Maiken Cavling Arendrup; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clinical Microbiology and Infection. 2019;25(10):1270–1274. doi:10.1016/j.cmi.2018.09.008
Multi-centre validation of 4-well azole agar plate as a screening method for detection of clinically relevant azole resistant Aspergillus fumigatus.
Maiken Cavling Arendrup, Paul E Verweij, Johan W Mouton, Katrien Lagrou, Joseph Meletiadis. Journal of Antimicrobial Chemotherapy, Volume 72, Issue 12, December 2017, Pages 3325–3333, https://doi.org/10.1093/jac/dkx319
Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus.
Meletiadis J, Leth Mortensen K, Verweij PE, Mouton JW, Arendrup MC, Clin Microbiol Infect. 2017;23(2):98-103.
EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.
Arendrup MC, Howard S, Lass-Flöhrl C, Mouton JW, Meletiadis J, Cuenca-Estrella M. 2014;58(11): 6432-6.
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaet T, Pukiskas SR, St-Germain G, Szeszs MW, Turnidge J. Antimicrob Agents Chemother. 2013 Dec;57(12):5836-42. doi: 10.1128/AAC.01519-13.
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW. Drug Res Update 2013;16(6):81-95.
Comparison of DMSO and water as solvents for echinocandins susceptibility testing by EUCAST methodology.
Alastruey-Izquierdo A, Gómez-López A, Arendrup MC, Lass-Florl C, Hope WW, Perlin DS, Rodriguez-Tudela JL, Cuenca-Estrella M. 2012. J Clin Microbiol. 50:2509-2012.
Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints.
JArendrup MC, Pfaller MA; Danish Fungaemia Study Group. Antimicrob Agents Chemother. 2012 Jul;56(7):3965-8.
Evaluation of Caspofungin Susceptibility Testing by the New VITEK(R) 2 AST-YS06 Yeast Card Using a Unique Collection of FKS Wild Type and Hot Spot Mutant Isolates Including the Five Most Common Candida Species.
Astvad KM, Perlin DS, Johansen HK, Jensen RH, Arendrup MC. Antimicrob Agents Chemother. 2012 57(1):177-82
Comparison of the VITEK 2 antifungal susceptibility system with the CLSI and the EUCAST broth microdilution reference methods and with the Sensititre Yeast-One and the Etest techniques for the detection in vitro of antifungal resistance in yeasts.
Cuenca-Estrella M, Gomez-Lopez A, Alastruey-Izquierdo A, Bernal-Martinez L, Cuesta I, Buitrago MJ, Rodriguez-Tudela JL. J Clin Microbiol 2010, 48(5):1782.
Multicenter comparison of the ISO standard 20776-1 and the serial 2-fold dilution procedures to dilute hydrophilic and hydrophobic antifungal agents for susceptibility testing.
Gomez-Lopez A, Arendrup MC, Lass-Floerl C, Rodriguez-Tudela JL, Cuenca-Estrella M. J Clin Microbiol 2010, 48(5):1918.
Echinocandin susceptibility testing of Candida species: comparison of EUCAST E.Def 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.
Arendrup MC, Garcia-Effron G, Lass-Flörl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS. Antimicrob Agents Chemother 2010; 54: 426-39.
Evaluation by data mining techniques of fluconazole breakpoints established by the clinical and laboratory standards institute (CLSI) and comparison with those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
Cuesta I, Bielza C, Cuenca-Estrella M, Larrañaga P, Rodríguez-Tudela JL. Antimicrob Agents Chemother 2010; 54: 1541-6.
EUCAST breakpoints for antifungals.
Rodriguez-Tudela JL, Arendrup MC, Cuenca-Estrella M, Donnelly JP, Lass-Florl C. Drug News Perspect 2010; 23: 93-7.
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.
Arendrup MC, Cuenca-Estrella M, Donnelly JP, Lass-Flörl C, Rodriguez-Tudela JL. Antimicrob Agents Chemother 2009; 53: 2704-5.
Data mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility Testing.
Cuesta I, Bielza C, Larrañaga P, Cuenca-Estrella M, Laguna F, Rodriguez-Pardo D, Almirante B, Pahissa A, Rodríguez-Tudela JL. Antimicrob Agents Chemother 2009; 53: 2949-54.
Breakpoints for susceptibility testing should not divide wild-type distributions of important target species.
Arendrup MC, Kahlmeter G, Rodriguez-Tudela JL, Donnelly JP. Antimicrob Agents Chemother 2009; 53:1628-9.
Antimicriobial susceptibility testing of Mycobacterium tuberculosis
Drobniewski F, Rüsch-Gerdes S, Hoffner S. EUCAST document E.DEF 8.1: antimicrobial susceptibility testing of Mycobacterium tuberculosis - Report of the Subcommittee on Antimicrobial Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). CMI 2007; 13:1144-56.
Comparison of EUCAST-AFST and CLSI methods for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
Chryssanthou E and Cuenca-Estrella M (2006) Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp. Clin Microbiol Infect; 12:901-904.
Looking for more information? Get in touch with an EUCAST representative today!
We’ve prepared a short video to help you get familiar with the new layout and features.